Skip to main content


8 result(s) for 'author#Anne Sofie Siebuhr' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. We aimed to investigate the prognostic value of two biomarkers of tissue inflammation, matrix metalloproteinase-dependent degradation of C-reactive protein (CRPM) and connective tissue type I collagen turnover...

    Authors: Fatemeh Saberi Hosnijeh, Anne Sofie Siebuhr, Andre G. Uitterlinden, Edwin H. G. Oei, Albert Hofman, Morten A. Karsdal, Sita M. Bierma-Zeinstra, Anne C. Bay-Jensen and Joyce B. J. van Meurs
    Citation: Arthritis Research & Therapy 2016 18:81
  2. Matrix metalloproteinase-3 (MMP-3) plays an important role in the pathology of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Measurement of active MMP-3 in clinical samples could provide informati...

    Authors: Shu Sun, Anne-Christine Bay-Jensen, Morten A Karsdal, Anne Sofie Siebuhr, Qinlong Zheng, Walter P Maksymowych, Thorbjørn G Christiansen and Kim Henriksen
    Citation: BMC Musculoskeletal Disorders 2014 15:93
  3. Rheumatoid arthritis (RA) patients with structural progression are in most need of immediate treatment to maintain tissue integrity. The serum protein fingerprint, type I collagen degradation mediated by matri...

    Authors: Anne Sofie Siebuhr, Anne C Bay-Jensen, Diana J Leeming, Adam Plat, Inger Byrjalsen, Claus Christiansen, Désirée van de Heijde and Morten A Karsdal
    Citation: Arthritis Research & Therapy 2013 15:R86
  4. Rheumatoid arthritis is a disease affecting the extracellular matrix of especially synovial joints. The thickness of the synovial membrane increases and surrounding tissue degrades, leading to altered collagen...

    Authors: Anne Sofie Siebuhr, Jianxia Wang, Morten Karsdal, Anne-C Bay-Jensen, Jin Y and Zheng Q
    Citation: Journal of Translational Medicine 2012 10:195
  5. Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are chronic inflammatory rheumatic diseases with complex origins. Both are characterized by altered extracellular matrix remodeling in joints and e...

    Authors: Natasja Stæhr Gudmann, Heidi Lausten Munk, Anne Friesgaard Christensen, Leif Ejstrup, Grith Lykke Sørensen, Anne Gitte Loft, Morten Asser Karsdal, Anne-Christine Bay-Jensen, Yi He, Anne Sofie Siebuhr and Peter Junker
    Citation: Arthritis Research & Therapy 2016 18:141
  6. Sprifermin (recombinant human fibroblast growth factor 18) is in clinical development as a potential disease-modifying osteoarthritis drug (DMOAD). In vitro studies have shown that cartilage regenerative prope...

    Authors: Ditte Reker, Cecilie F. Kjelgaard-Petersen, Anne Sofie Siebuhr, Martin Michaelis, Anne Gigout, Morten A. Karsdal, Christoph Ladel and Anne C. Bay-Jensen
    Citation: Journal of Translational Medicine 2017 15:250
  7. Osteoarthritis (OA) is the most common degenerative joint disease, of which the pathogenesis is inadequately understood. Hypertrophy-like changes have been observed as part of the progression of OA. The aim of...

    Authors: Yi He, Anne Sofie Siebuhr, Niels Ulrik Brandt-Hansen, Jianxia Wang, Di Su, Qinlong Zheng, Ole Simonsen, Kristian Kjær Petersen, Lars Arendt-Nielsen, Thomas Eskehave, Hans Christian Hoeck, Morten Asser Karsdal and Anne C Bay-Jensen
    Citation: BMC Musculoskeletal Disorders 2014 15:309
  8. Rheumatoid arthritis (RA) is characterized by gradual joint destruction. Tocilizumab (TCZ) significantly suppresses symptoms, however not all patients are protected from joint damage. We investigated whether e...

    Authors: Anne C. Bay-Jensen, Adam Platt, Anne Sofie Siebuhr, Claus Christiansen, Inger Byrjalsen and Morten A. Karsdal
    Citation: Arthritis Research & Therapy 2016 18:13